课题基金 / 基金详情

Pathogenesis and therapeutic targeting of immune disorders

Pathogenesis and therapeutic targeting of immune disorders
免疫性疾病的发病机制和治疗靶点
批准号:
9925180
负责人:
David A Hildeman
金额:
$13.15万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2021-06-30

项目摘要

项目成果

David A Hildeman的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/文摘
英文摘要
Project Summary/Abstract Dysregulated immune responses are of central importance to the pathogenesis and expression of a wide spectrum of diseases that cause an immense burden of morbidity and mortality. The overall Aim of the training grant is to provide training for 3 pre-doctoral candidates, whose research will uncover pathogenic mechanisms of immune-mediated disease and facilitate transformative therapeutic approaches, consistent with the mission of the NIH. Candidates will be recruited from the Immunology Graduate Program (ImmGP) and the Medical Scientist Training Program at Cincinnati Children’s Hospital Medical Center (CCHMC) and the University of Cincinnati College of Medicine (UCCOM). Housed within CCHMC, one of the premiere pediatric research institutions in the US, the ImmGP attracts a strong and diverse pool of applicants. ImmGP students receive exemplary didactic instruction in immunology, research ethics, grant writing, and biostatistics. The training program will be led by a Director and Co-Director (Drs. Hildeman and Singh) who, along with 34 outstanding Training Faculty (TF), have significant experience in mentoring pre-doctoral students. Students will work with a diverse group of TF (comprised of MDs, MD/PhDs, and PhDs), from multiple departments at CCHMC/UCCOM, who share a collective focus on the mechanistic understanding of the immunologic basis of human disease. Students in this training program will be immersed in a distinctive environment: TF have well-funded research programs that span basic immunology to animal models of disease to clinical trials in human patients; CCHMC provides tremendous institutional resources (e.g., support for graduate education and faculty research, cutting- edge core facilities, unique patient cohorts); a collaborative research student exchange program with a German University and Research Institute provides a unique opportunity for international studies in immunology. Graduates of this program will be uniquely poised to bring innovations in immunology from the laboratory bench to the bedside and will be well-prepared for independent research careers.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Erratum: Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells.
勘误表:用表达嵌合抗原受体的自然杀伤细胞对滤泡 T 细胞进行治疗性靶向。
DOI: 10.1016/j.xcrm.2020.100080
发表时间: 2020
期刊: Cell reports. Medicine
影响因子: --
作者: [Reighard,SethD, Cranert,StaceyA, Rangel,KellyM, Ali,Ayad, Gyurova,IvaylaE, delaCruz-Lynch,ArthurT, Tuazon,JasmineA, Khodoun,MaratV, Kottyan,LeahC, Smith,DavidF, Brunner,HermineI, Waggoner,StephenN]
通讯作者: Waggoner,StephenN
Pathogenesis and therapeutic targeting of immune disorders
  • 批准号:
    9308845
  • 项目类别:
  • 资助金额:
    $14.21万
  • 财政年份:
    2016
  • 负责人:
    David A Hildeman
  • 依托单位:
Pathogenesis and therapeutic targeting of immune disorders
  • 批准号:
    9149365
  • 项目类别:
  • 资助金额:
    $14.06万
  • 财政年份:
    2016
  • 负责人:
    David A Hildeman
  • 依托单位:
Exploiting the DNA damage response to selectively sculpt the T cellrepertoire
Exploiting the DNA damage response to selectively sculpt the T cellrepertoire
海外基金